Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.
(2012) In Breast Cancer Research and Treatment 131. p.33-40- Abstract
- Global gene expression profiles, consisting mainly of genes associated with proliferation, have been shown to subdivide histological grade 2 breast cancers into groups with different prognosis. We raised the question whether this subdivision could be done using a single proliferation marker, cyclin A. Furthermore, we combined cyclin A (CA), histological grade (G), and estrogen receptor-ER (E) into a new variable, CAGE. Our aim was to investigate not only the prognostic importance of cyclin A alone but also the value of the combination variable CAGE. In 219 premenopausal node-negative patients, cyclin A was assessed using immunohistochemistry on tissue microarrays. High cyclin A was defined as above the seventh decile of positive cells.... (More)
- Global gene expression profiles, consisting mainly of genes associated with proliferation, have been shown to subdivide histological grade 2 breast cancers into groups with different prognosis. We raised the question whether this subdivision could be done using a single proliferation marker, cyclin A. Furthermore, we combined cyclin A (CA), histological grade (G), and estrogen receptor-ER (E) into a new variable, CAGE. Our aim was to investigate not only the prognostic importance of cyclin A alone but also the value of the combination variable CAGE. In 219 premenopausal node-negative patients, cyclin A was assessed using immunohistochemistry on tissue microarrays. High cyclin A was defined as above the seventh decile of positive cells. Only 13% of the patients received adjuvant systemic therapy. Cox proportional hazards regression was used to model the impact of the factors on distant disease-free survival (DDFS). Cyclin A divided histological grade 2 tumors into two groups with significantly different DDFS (hazard ratio [HR]: 15, P < 0.001). When stratifying for ER status, cyclin A was a prognostic factor only in the ER positive subgroup. We found that CAGE was an independent prognostic factor for DDFS in multivariate analysis (HR: 4.1, P = 0.002), together with HER2. CAGE and HER2 identified 53% as low-risk patients with a 5-year DDFS of 95%. A new prognostic variable was created by combining cyclin A, histological grade, and ER (CAGE). CAGE together with HER2 identified a large low-risk group for whom adjuvant chemotherapy will have limited efficacy and may be avoided. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1831669
- author
- Forsare, Carina LU ; Ahlin, Cecilia ; Bendahl, Pär-Ola LU ; Fjällskog, Marie-Louise ; Hedenfalk, Ingrid LU ; Malmström, Per LU and Fernö, Mårten LU
- organization
- publishing date
- 2012
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Breast Cancer Research and Treatment
- volume
- 131
- pages
- 33 - 40
- publisher
- Springer
- external identifiers
-
- wos:000298006300004
- pmid:21331623
- scopus:84856226232
- pmid:21331623
- ISSN
- 1573-7217
- DOI
- 10.1007/s10549-011-1386-5
- language
- English
- LU publication?
- yes
- id
- 53537312-c43d-41dd-a0ae-440ec826a0ca (old id 1831669)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/21331623?dopt=Abstract
- date added to LUP
- 2016-04-01 13:53:55
- date last changed
- 2022-02-19 08:03:08
@article{53537312-c43d-41dd-a0ae-440ec826a0ca, abstract = {{Global gene expression profiles, consisting mainly of genes associated with proliferation, have been shown to subdivide histological grade 2 breast cancers into groups with different prognosis. We raised the question whether this subdivision could be done using a single proliferation marker, cyclin A. Furthermore, we combined cyclin A (CA), histological grade (G), and estrogen receptor-ER (E) into a new variable, CAGE. Our aim was to investigate not only the prognostic importance of cyclin A alone but also the value of the combination variable CAGE. In 219 premenopausal node-negative patients, cyclin A was assessed using immunohistochemistry on tissue microarrays. High cyclin A was defined as above the seventh decile of positive cells. Only 13% of the patients received adjuvant systemic therapy. Cox proportional hazards regression was used to model the impact of the factors on distant disease-free survival (DDFS). Cyclin A divided histological grade 2 tumors into two groups with significantly different DDFS (hazard ratio [HR]: 15, P < 0.001). When stratifying for ER status, cyclin A was a prognostic factor only in the ER positive subgroup. We found that CAGE was an independent prognostic factor for DDFS in multivariate analysis (HR: 4.1, P = 0.002), together with HER2. CAGE and HER2 identified 53% as low-risk patients with a 5-year DDFS of 95%. A new prognostic variable was created by combining cyclin A, histological grade, and ER (CAGE). CAGE together with HER2 identified a large low-risk group for whom adjuvant chemotherapy will have limited efficacy and may be avoided.}}, author = {{Forsare, Carina and Ahlin, Cecilia and Bendahl, Pär-Ola and Fjällskog, Marie-Louise and Hedenfalk, Ingrid and Malmström, Per and Fernö, Mårten}}, issn = {{1573-7217}}, language = {{eng}}, pages = {{33--40}}, publisher = {{Springer}}, series = {{Breast Cancer Research and Treatment}}, title = {{Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.}}, url = {{https://lup.lub.lu.se/search/files/3653231/1848360.pdf}}, doi = {{10.1007/s10549-011-1386-5}}, volume = {{131}}, year = {{2012}}, }